Skeletal muscle mass is not merely an aesthetic concern — it is a critical biomarker of metabolic health, fall resistance, and all-cause mortality risk. A comprehensive narrative review now bridges the molecular underpinnings of muscle growth with actionable programming variables, offering one of the most integrated frameworks to date for clinicians, coaches, and health-conscious adults seeking to preserve or build lean mass across the lifespan.
The review synthesized literature from 2010 to 2024, prioritizing randomized controlled trials, systematic reviews, and mechanistic studies. At the cellular level, hypertrophy is driven primarily by mechanotransduction cascades that activate mTORC1, a master regulatory kinase governing protein synthesis. Practically, the evidence converges on weekly training volume as a central dose variable — approximately 10 to 20 sets per muscle group per week — performed at near-failure intensity (roughly 0–2 repetitions in reserve). Distributing this volume across multiple sessions appears to preserve training quality better than concentrating it in fewer bouts. On the nutritional side, protein intake of approximately 1.6 g/kg/day emerged as the evidence-supported minimum, with ranges up to 2.2 g/kg/day showing incremental benefit in certain contexts, particularly when energy availability is restricted.
This synthesis is valuable precisely because it connects mechanism to method: understanding that mTORC1 activation depends on both mechanical load and amino acid availability explains why neither training nor nutrition alone is sufficient. The review's level-4 evidence designation — narrative rather than systematic — is a meaningful caveat; pooling effect sizes across heterogeneous training populations remains methodologically complex, and individual variation in hypertrophic response is substantial. Nonetheless, the protein and volume thresholds reported here are among the most replicated findings in applied exercise science. For adults concerned about sarcopenia — the age-related loss of muscle that accelerates after the fifth decade — these parameters represent not just performance guidance but a longevity-relevant intervention framework. The convergence of molecular and practical evidence makes this an incrementally confirmatory but unusually well-organized resource.